A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of unknown origin.
Some professionals said the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Removal
According to the social media company, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or administering at home.
After minutes of joining one group, a seller shared contact information, where most purchases take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.
Product Details and Pricing
Inside these groups, posts display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious medical dangers”.
